Ductal Carcinoma In Situ (DCIS) is an early stage cancer, but that does not mean it needs no treatment. It usually remains within the milk ducts, but doctors recommend evaluation to prevent possible progression. Our team at the CK Birla Hospital provides thorough evaluation and personalised treatment plans to help patients understand their diagnosis and make informed decisions about their care.
Ductal carcinoma in situ (DCIS) is a condition in which abnormal cells develop inside the milk ducts of the breast. The term ‘in situ’ means ‘in its original place.’ This means the abnormal cells have not invaded nearby breast tissue or spread to other parts of the body.
Although DCIS disease is not considered invasive breast cancer, it requires medical attention because some untreated cases may eventually develop into invasive breast cancer over time.
DCIS is commonly detected through routine mammograms before symptoms appear, making regular breast screening an important part of early diagnosis.
It develops when genetic changes occur within the cells lining the milk ducts, causing them to grow abnormally. Medical researchers believe that a combination of genetic, hormonal, and environmental factors are responsible for the development of DCIS. In many cases, there is no single identifiable cause.
There are several factors that may increase the likelihood of developing ductal carcinoma in situ.
The risk of DCIS rises as women get older, particularly after the age of 50.
Women with close relatives who have had breast cancer may have a higher risk.
Inherited mutations such as BRCA1 and BRCA2 can increase the risk of breast cancer, including DCIS.
A personal history of breast abnormalities or breast cancer may increase the likelihood of developing DCIS.
Long-term exposure to estrogen due to early menstruation, late menopause or certain hormone therapies may increase the risk.
Obesity, physical inactivity and excessive alcohol consumption have been associated with an increased risk of breast cancer.
Most women with DCIS breast cancer do not experience evident symptoms. The condition is usually detected during routine breast imaging.
When symptoms occur, they can be:
The DCIS treatment is done to remove abnormal cells and reduce the risk of the condition returning or progressing to invasive breast cancer.
Treatment recommendations depend on factors such as the size of the affected area, its location, cell characteristics and the overall health of the patient.
A lumpectomy involves removing the area containing DCIS while preserving most of the breast tissue. This option is suitable when the affected area is small and localised. It is commonly followed by radiation therapy to reduce the chance of recurrence.
Recovery after ductal cancer treatment varies depending on the procedure performed. Most patients can return to normal daily activities within a few weeks following breast conserving surgery. Recovery after mastectomy may take longer.
Post-treatment care can look like:
Patients are encouraged to discuss any concerns regarding healing, body image or long-term followup with their healthcare team.
Choosing the right hospital is an important part of breast cancer care. We, at the CK Birla Hospital, follow a collaborative approach to breast cancer care, where diagnosis and treatment planning is designed for each patient. Within our dedicated ‘Breast Centre’, specialists from different fields work together to ensure coordinated support throughout the treatment process. The team works closely with patients and their families to ensure they understand each stage of the treatment journey.
Our patients benefit from:
If you have been diagnosed with DCIS or have concerns about abnormal mammogram findings, early consultation can help clarify your treatment options.
Schedule an appointment with our breast care specialists at the CK Birla Hospital to receive expert guidance.
In many cases, DCIS can be successfully treated when detected early. Treatment aims to remove abnormal cells and reduce the risk of progression to invasive breast cancer.
The risk of recurrence varies depending on factors such as the size of the lesion, treatment received and individual patient characteristics. Following the recommended treatment plan and attending regular followup appointments can help manage this risk.
Maintaining a healthy lifestyle, attending routine breast screenings and discussing personal risk factors with a healthcare provider may help support early detection and risk reduction.
DCIS itself is confined to the milk ducts and is non-invasive. However, if left untreated, some cases may progress to invasive breast cancer. This is why timely diagnosis and appropriate treatment are recommended.
